Fox Run Management’s Amicus Therapeutics FOLD Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q2
Sell
2025
Q1
$175K Sell
2024
Q4
$589K Buy
2024
Q3
$346K Buy
2023
Q1
Sell
2022
Q4
$150K Sell
2022
Q3
$132K Buy
2021
Q4
Sell
2021
Q3
$264K Buy
2019
Q3
Sell
2019
Q2
$204K Buy
2018
Q4
Sell
2018
Q3
$147K Sell
2018
Q2
$318K Buy